JPH04134043A - New alpha-benzylidene ketone derivative, ultraviolet absorber and cosmetic containing said absorber - Google Patents
New alpha-benzylidene ketone derivative, ultraviolet absorber and cosmetic containing said absorberInfo
- Publication number
- JPH04134043A JPH04134043A JP25473890A JP25473890A JPH04134043A JP H04134043 A JPH04134043 A JP H04134043A JP 25473890 A JP25473890 A JP 25473890A JP 25473890 A JP25473890 A JP 25473890A JP H04134043 A JPH04134043 A JP H04134043A
- Authority
- JP
- Japan
- Prior art keywords
- group
- benzylidene
- ketone derivative
- formula
- absorber
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 22
- 239000006097 ultraviolet radiation absorber Substances 0.000 title claims abstract description 8
- 239000006096 absorbing agent Substances 0.000 title description 13
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 4
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims abstract description 3
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims abstract description 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims abstract description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims abstract description 3
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 3
- 125000002947 alkylene group Chemical group 0.000 claims abstract 3
- 125000003302 alkenyloxy group Chemical group 0.000 claims abstract 2
- 125000005702 oxyalkylene group Chemical group 0.000 claims abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- 125000004434 sulfur atom Chemical group 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- 239000000126 substance Substances 0.000 claims 1
- QNXSIUBBGPHDDE-UHFFFAOYSA-N indan-1-one Chemical compound C1=CC=C2C(=O)CCC2=C1 QNXSIUBBGPHDDE-UHFFFAOYSA-N 0.000 abstract description 9
- 206010042496 Sunburn Diseases 0.000 abstract description 4
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 abstract description 3
- 150000003935 benzaldehydes Chemical class 0.000 abstract description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzenecarboxaldehyde Natural products O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 abstract description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 abstract description 2
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000003405 preventing effect Effects 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 40
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 150000001875 compounds Chemical class 0.000 description 21
- -1 methylenedioxy group Chemical group 0.000 description 18
- 235000019441 ethanol Nutrition 0.000 description 17
- 230000000694 effects Effects 0.000 description 16
- 239000000203 mixture Substances 0.000 description 15
- 230000015572 biosynthetic process Effects 0.000 description 12
- 239000013078 crystal Substances 0.000 description 12
- 239000003921 oil Substances 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 235000011118 potassium hydroxide Nutrition 0.000 description 10
- 238000003786 synthesis reaction Methods 0.000 description 10
- GOUHYARYYWKXHS-UHFFFAOYSA-N 4-formylbenzoic acid Chemical compound OC(=O)C1=CC=C(C=O)C=C1 GOUHYARYYWKXHS-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 238000005160 1H NMR spectroscopy Methods 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 5
- UHKAJLSKXBADFT-UHFFFAOYSA-N 1,3-indandione Chemical compound C1=CC=C2C(=O)CC(=O)C2=C1 UHKAJLSKXBADFT-UHFFFAOYSA-N 0.000 description 4
- BBMCTIGTTCKYKF-UHFFFAOYSA-N 1-heptanol Chemical compound CCCCCCCO BBMCTIGTTCKYKF-UHFFFAOYSA-N 0.000 description 4
- JIVGSHFYXPRRSZ-UHFFFAOYSA-N 2,3-dimethoxybenzaldehyde Chemical compound COC1=CC=CC(C=O)=C1OC JIVGSHFYXPRRSZ-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 229940057995 liquid paraffin Drugs 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- XHLHPRDBBAGVEG-UHFFFAOYSA-N 1-tetralone Chemical compound C1=CC=C2C(=O)CCCC2=C1 XHLHPRDBBAGVEG-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- QTMKMLMMSDDCIP-JLHYYAGUSA-N (3e)-3-[(4-methoxyphenyl)methylidene]chromen-4-one Chemical compound C1=CC(OC)=CC=C1\C=C/1C(=O)C2=CC=CC=C2OC\1 QTMKMLMMSDDCIP-JLHYYAGUSA-N 0.000 description 2
- BWCXIEOVFGKDBR-UHFFFAOYSA-N 2-[(4-methoxyphenyl)methylidene]indene-1,3-dione Chemical compound C1=CC(OC)=CC=C1C=C1C(=O)C2=CC=CC=C2C1=O BWCXIEOVFGKDBR-UHFFFAOYSA-N 0.000 description 2
- IAVREABSGIHHMO-UHFFFAOYSA-N 3-hydroxybenzaldehyde Chemical compound OC1=CC=CC(C=O)=C1 IAVREABSGIHHMO-UHFFFAOYSA-N 0.000 description 2
- WMPDAIZRQDCGFH-UHFFFAOYSA-N 3-methoxybenzaldehyde Chemical compound COC1=CC=CC(C=O)=C1 WMPDAIZRQDCGFH-UHFFFAOYSA-N 0.000 description 2
- MSTDXOZUKAQDRL-UHFFFAOYSA-N 4-Chromanone Chemical compound C1=CC=C2C(=O)CCOC2=C1 MSTDXOZUKAQDRL-UHFFFAOYSA-N 0.000 description 2
- ZKHJNABQNGURHC-UHFFFAOYSA-N 4-[(3-oxo-1h-inden-2-ylidene)methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C=C1C(=O)C2=CC=CC=C2C1 ZKHJNABQNGURHC-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 230000006750 UV protection Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical class C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- PQNFLJBBNBOBRQ-UHFFFAOYSA-N indane Chemical compound C1=CC=C2CCCC2=C1 PQNFLJBBNBOBRQ-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- SATCULPHIDQDRE-UHFFFAOYSA-N piperonal Chemical compound O=CC1=CC=C2OCOC2=C1 SATCULPHIDQDRE-UHFFFAOYSA-N 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- SMQUZDBALVYZAC-UHFFFAOYSA-N salicylaldehyde Chemical compound OC1=CC=CC=C1C=O SMQUZDBALVYZAC-UHFFFAOYSA-N 0.000 description 2
- WJUFSDZVCOTFON-UHFFFAOYSA-N veratraldehyde Chemical compound COC1=CC=C(C=O)C=C1OC WJUFSDZVCOTFON-UHFFFAOYSA-N 0.000 description 2
- CSUUDNFYSFENAE-UHFFFAOYSA-N (2-methoxyphenyl)-phenylmethanone Chemical compound COC1=CC=CC=C1C(=O)C1=CC=CC=C1 CSUUDNFYSFENAE-UHFFFAOYSA-N 0.000 description 1
- MTRGPBISOZJVME-JLHYYAGUSA-N (2e)-2-[(2-hydroxyphenyl)methylidene]-3h-inden-1-one Chemical compound OC1=CC=CC=C1\C=C/1C(=O)C2=CC=CC=C2C\1 MTRGPBISOZJVME-JLHYYAGUSA-N 0.000 description 1
- VBOMEZWDBOXOKE-GXDHUFHOSA-N (2e)-2-[(4-methoxyphenyl)methylidene]-3h-inden-1-one Chemical compound C1=CC(OC)=CC=C1\C=C/1C(=O)C2=CC=CC=C2C\1 VBOMEZWDBOXOKE-GXDHUFHOSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- SEPPVOUBHWNCAW-FNORWQNLSA-N (E)-4-oxonon-2-enal Chemical compound CCCCCC(=O)\C=C\C=O SEPPVOUBHWNCAW-FNORWQNLSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- BVZSOCSACJYPJV-UHFFFAOYSA-N 1-dodecoxydodecane;ethanol Chemical compound CCO.CCCCCCCCCCCCOCCCCCCCCCCCC BVZSOCSACJYPJV-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- LALVCWMSKLEQMK-UHFFFAOYSA-N 1-phenyl-3-(4-propan-2-ylphenyl)propane-1,3-dione Chemical compound C1=CC(C(C)C)=CC=C1C(=O)CC(=O)C1=CC=CC=C1 LALVCWMSKLEQMK-UHFFFAOYSA-N 0.000 description 1
- CVQSWZMJOGOPAV-UHFFFAOYSA-N 2,3-dihydrothiochromen-4-one Chemical compound C1=CC=C2C(=O)CCSC2=C1 CVQSWZMJOGOPAV-UHFFFAOYSA-N 0.000 description 1
- PKZJLOCLABXVMC-UHFFFAOYSA-N 2-Methoxybenzaldehyde Chemical compound COC1=CC=CC=C1C=O PKZJLOCLABXVMC-UHFFFAOYSA-N 0.000 description 1
- MTRGPBISOZJVME-UHFFFAOYSA-N 2-[(2-hydroxyphenyl)methylidene]-3h-inden-1-one Chemical compound OC1=CC=CC=C1C=C1C(=O)C2=CC=CC=C2C1 MTRGPBISOZJVME-UHFFFAOYSA-N 0.000 description 1
- OHWCWTZNVDCVPV-UHFFFAOYSA-N 2-[3-(4-methoxyphenyl)-3-oxopropanoyl]benzoic acid Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=CC=C1C(O)=O OHWCWTZNVDCVPV-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- UHDNUPHSDMOGCR-UHFFFAOYSA-N 3-Formylbenzoic acid Chemical compound OC(=O)C1=CC=CC(C=O)=C1 UHDNUPHSDMOGCR-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- YDIYEOMDOWUDTJ-UHFFFAOYSA-N 4-(dimethylamino)benzoic acid Chemical class CN(C)C1=CC=C(C(O)=O)C=C1 YDIYEOMDOWUDTJ-UHFFFAOYSA-N 0.000 description 1
- UZFMOKQJFYMBGY-UHFFFAOYSA-N 4-hydroxy-TEMPO Chemical compound CC1(C)CC(O)CC(C)(C)N1[O] UZFMOKQJFYMBGY-UHFFFAOYSA-N 0.000 description 1
- LLBZPESJRQGYMB-UHFFFAOYSA-N 4-one Natural products O1C(C(=O)CC)CC(C)C11C2(C)CCC(C3(C)C(C(C)(CO)C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)CO5)OC5C(C(OC6C(C(O)C(O)C(CO)O6)O)C(O)C(CO)O5)OC5C(C(O)C(O)C(C)O5)O)O4)O)CC3)CC3)=C3C2(C)CC1 LLBZPESJRQGYMB-UHFFFAOYSA-N 0.000 description 1
- RDBLNMQDEWOUIB-UHFFFAOYSA-N 5-methyl-2-phenyl-1,3-benzoxazole Chemical compound N=1C2=CC(C)=CC=C2OC=1C1=CC=CC=C1 RDBLNMQDEWOUIB-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 235000011960 Brassica ruvo Nutrition 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 201000006082 Chickenpox Diseases 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- GTEVUWRNSZUINE-UHFFFAOYSA-N OCC(O)CO.OCCN(CCO)CCO.COC(=O)C1=CC=C(O)C=C1 Chemical compound OCC(O)CO.OCCN(CCO)CCO.COC(=O)C1=CC=C(O)C=C1 GTEVUWRNSZUINE-UHFFFAOYSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005336 allyloxy group Chemical group 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- WAATURCSKZMXLM-UHFFFAOYSA-N ethyl 4-hydroxybenzoate;methyl 4-hydroxybenzoate Chemical compound COC(=O)C1=CC=C(O)C=C1.CCOC(=O)C1=CC=C(O)C=C1 WAATURCSKZMXLM-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940089456 isopropyl stearate Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- UQDVHJGNIFVBLG-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O UQDVHJGNIFVBLG-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 125000005704 oxymethylene group Chemical group [H]C([H])([*:2])O[*:1] 0.000 description 1
- AFDXODALSZRGIH-UHFFFAOYSA-N p-coumaric acid methyl ether Natural products COC1=CC=C(C=CC(O)=O)C=C1 AFDXODALSZRGIH-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- LYXOWKPVTCPORE-UHFFFAOYSA-N phenyl-(4-phenylphenyl)methanone Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1C(=O)C1=CC=CC=C1 LYXOWKPVTCPORE-UHFFFAOYSA-N 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 239000003586 protic polar solvent Substances 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- JNUBZSFXMKCDFD-UHFFFAOYSA-M sodium;2-phenyl-3h-benzimidazole-5-sulfonate Chemical compound [Na+].N1C2=CC(S(=O)(=O)[O-])=CC=C2N=C1C1=CC=CC=C1 JNUBZSFXMKCDFD-UHFFFAOYSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、紫外線吸収作用を有し、かつ卓越した光安定
性を有する新規なα−ベンジリデンケトン誘導体、及び
それを含有し、日焼は防止効果の優れた紫外線吸収剤及
び化粧料に関する。Detailed Description of the Invention [Industrial Field of Application] The present invention provides a novel α-benzylidene ketone derivative that has an ultraviolet absorbing effect and excellent photostability, and a novel α-benzylidene ketone derivative containing the same, which is resistant to sunburn. This invention relates to ultraviolet absorbers and cosmetics with excellent UV protection effects.
紫外線はさまざまな変化を皮膚にもたらすことが知られ
ている。皮膚科学的には作用波長を、400〜320n
mの長波長紫外線、320〜29Or+mの中波長紫外
線及び290nm以下の短波長紫外線に分け、それぞれ
UV−八、UV−8及びLIV−Cと呼んでいる。太陽
光線中の紫外線はIIV−八及びIIV−8であり、U
V−Cは才シン層において吸収された地上にはほとんど
達しない。Ultraviolet rays are known to cause various changes in the skin. Dermatologically, the working wavelength is 400 to 320n.
Ultraviolet rays are divided into long-wavelength ultraviolet rays of m, medium-wavelength ultraviolet rays of 320 to 29 Or+m, and short-wavelength ultraviolet rays of 290 nm or less, and are called UV-8, UV-8, and LIV-C, respectively. The ultraviolet rays in sunlight are IIV-8 and IIV-8, and U
V-C is absorbed in the Saishin layer and hardly reaches the ground.
uv−eはある一定以上の光量が皮膚に照射されると紅
斑や水痘を形成し、またメラニン形成を冗進し、色素沈
着を生ずる等の変化を皮膚にもたらす。When UV-E is irradiated to the skin with a certain amount of light, it causes changes in the skin, such as the formation of erythema and chickenpox, as well as accelerated melanin formation and pigmentation.
これに対しUV−Aは照射直後に皮膚を黒化させる作用
(即時黒化)を引き起こし、またそのエネルギは真皮に
まで到達するた必、血管壁や結合組織中の弾性線維に変
化をもたらす。このようなIIV−Aの作用は、皮膚の
老化を促進し、しみ、しわ、ソバカスなどの一因子とな
っていると考えられている。On the other hand, UV-A causes a blackening effect on the skin (immediate blackening) immediately after irradiation, and as the energy reaches the dermis, it causes changes in blood vessel walls and elastic fibers in connective tissue. Such action of IIV-A accelerates skin aging and is thought to be a factor in the appearance of age spots, wrinkles, and freckles.
この様な紫外線のヒトの皮膚に及ぼず影響が明らかにな
るに従い、UV−Aを吸収する化合物の開発が行われる
ようになって来た。こうした紫外線吸収剤は次の条件を
すべて満足することが望ましいとされている。As the effects of ultraviolet rays on human skin have become clearer, compounds that absorb UV-A have been developed. It is said that it is desirable that such ultraviolet absorbers satisfy all of the following conditions.
■ IIV−Aの光を可能な限り完全に吸収すること。■ Absorb IIV-A light as completely as possible.
■ 光や熱に対して安定であること。■ Stable against light and heat.
■ 皮膚に対する毒性、削激性更に他の有害作用がない
こと。■ No toxicity, irritation or other harmful effects on the skin.
■ 効果が持続すること。■ Effects should last.
■ 化粧品基剤との相溶性に優れていること。■ Excellent compatibility with cosmetic bases.
従来、UV−A吸収剤としては例えばジベンゾイルメタ
ン誘導体等が用いられてきゾこ。Conventionally, for example, dibenzoylmethane derivatives have been used as UV-A absorbers.
しかし、これら従来の紫外線吸収剤は必ずしも上記の条
件を充分満足するものではなく、特に光に対する安定性
は不充分であり、紫外線による分解や反応が起こる事が
知られているC1nt、 JCosmetic 5ci
ence、 10.53(1988)E oこうした紫
外線吸収剤の分解は、効果の持続の低下を招くのみなら
ず、分解物自身あるいは配合物との反応によって生成し
た生成物の皮膚への影響も無視できない〔フレグランス
ジャーナル、 84.34(1987))。However, these conventional ultraviolet absorbers do not necessarily fully satisfy the above conditions, and in particular their stability against light is insufficient, and C1nt and JCosmetic 5ci, which are known to decompose or react with ultraviolet light,
ence, 10.53 (1988) E o Such decomposition of UV absorbers not only leads to a decrease in the duration of their effects, but also ignores the effects on the skin of the decomposed products themselves or the products generated by reactions with the formulations. I can't [Fragrance Journal, 84.34 (1987)].
従って、前記条件を満足する紫外線吸収剤、特に光に対
する安定性に優れた紫外線吸収剤が望まれていた。Therefore, there has been a desire for an ultraviolet absorber that satisfies the above conditions, particularly an ultraviolet absorber that has excellent stability against light.
斯かる実情に鑑み、本発明者らは数多くのαベンジリデ
ンケトン誘導体を合成し、その性質を検討してきたとこ
ろ、後記一般式(1)で表わされる新規α−ベンジリデ
ンケトン誘導体が優れたUV−へ吸収作用を有し、かつ
光に対して極狛で安定であること、更にこれを配合すれ
ば優れた日焼げ防止効果を有する化粧料が得られること
を見出し、本発明を完成した。In view of these circumstances, the present inventors have synthesized a number of α-benzylidene ketone derivatives and studied their properties, and found that a novel α-benzylidene ketone derivative represented by the general formula (1) below has excellent UV-resistance. The present invention was completed based on the discovery that it has an absorbing effect and is extremely stable against light, and that by blending it, a cosmetic with an excellent sunburn prevention effect can be obtained.
すなわち、本発明は次の一般式M)
(式中、n個のRは同一でも異なっていてもよく、それ
ぞれ水酸基、アルコキシ基、了りルオキシ基、アラルキ
ルオキシ基、カルボキシル基、アルコキシカルボニル基
又はアミノカルボニル基を示すか、又は2個のRでα−
メチレンジオキシ基を形成してもよい。nは1〜3の整
数を示し、Xは炭素数1〜3のアルキレン薦、カルボニ
ル基、酸素原子、硫黄原子、炭素数1〜2のオキシアル
キレン基又は炭素数1〜2のチオアルキレン基を示す)
で表わされるα−ベンジリデンケトン誘導体、これを含
有する紫外線吸収剤及び化粧料を提供するものである。That is, the present invention relates to the following general formula M) (wherein, n R's may be the same or different, and each represents a hydroxyl group, an alkoxy group, an araloxy group, an aralkyloxy group, a carboxyl group, an alkoxycarbonyl group, or represents an aminocarbonyl group, or α-
A methylenedioxy group may also be formed. n represents an integer of 1 to 3; show)
The present invention provides an α-benzylidene ketone derivative represented by the following, and ultraviolet absorbers and cosmetics containing the α-benzylidene ketone derivative.
上記一般式(1)中、Rの具体例としては水酸基、メト
キシ基、エトキシ基、プロポキシ基、アリルオキシ基、
t−ブトキシ基、ベンジルオキシ基、メチレンジオキシ
基、カルボキシル基、メトキシカルボニル基、エトキシ
カルボニル基、ジメチルアミノカルボニル基、ジエチル
アミノカルボニル基等が挙げられる。Xの具体例として
は、メチレン基、エチレン基、プロピレン基、カルボニ
ル基、酸素原子、硫黄原子、オキシメチレン基、オキシ
エチレン基、チオメチレン基、チオエチレン基等が挙げ
られる。In the above general formula (1), specific examples of R include a hydroxyl group, a methoxy group, an ethoxy group, a propoxy group, an allyloxy group,
Examples include t-butoxy group, benzyloxy group, methylenedioxy group, carboxyl group, methoxycarbonyl group, ethoxycarbonyl group, dimethylaminocarbonyl group, diethylaminocarbonyl group, and the like. Specific examples of X include methylene group, ethylene group, propylene group, carbonyl group, oxygen atom, sulfur atom, oxymethylene group, oxyethylene group, thiomethylene group, thioethylene group, and the like.
本発明のα−ベンジリデンケトン誘導体(I)は、例え
ば次の式に従い製造することができる。The α-benzylidene ketone derivative (I) of the present invention can be produced, for example, according to the following formula.
(II)
(I)
〔式中、R,n及びXは前記と同じものを示す〕すなわ
ち、縮環フェニルケトン(II)と置換ベンズアルデヒ
ド(I)を塩基の存在下縮合することにより本発明のα
−ベンジリデンケトン誘導体(I)が製造される。この
反応に用いられる縮環フェニルケトン(n)としては1
−インダノン、1.3−インダンジオン、ジヒドロベン
ゾフラン3−オン、ジヒドロベンゾチオフェン−3−オ
ン、テトラロン、ジヒドロクロモン、ジヒドロティラン
−4−オン、ペンゾスベロン等が挙げられる。(II) (I) [In the formula, R, n and α
- A benzylidene ketone derivative (I) is produced. The condensed phenyl ketone (n) used in this reaction is 1
-indanone, 1,3-indanedione, dihydrobenzofuran-3-one, dihydrobenzothiophen-3-one, tetralone, dihydrochromone, dihydrothyran-4-one, penzosuberone and the like.
方、置換ベンズアルデヒド(I[I)としては、0−メ
トキシベンズアルデヒド、m−メトキシベンズアルデヒ
ド、p−メトキシベンズアルデヒド、2.3−ジメトキ
シベンズアルデヒド、2.4ジメトキシベンズアルデヒ
ド、3,4−ジメトキシベンズアルデヒド、3,4.5
−)ジメトキシベンズアルデヒド、3,4−メチレンジ
オキシベンズアルデヒド、0−ヒドロキシベンズアルデ
ヒド、m−ヒドロキシベンズアルデヒド、p−ヒドロキ
シベンズアルデヒド、0−ホルミル安息香酸及びそのエ
ステル類ならびにそのアミド類、mホルミル安息香酸及
びそのエステル類ならびにそのアミド類、p−ホルミル
安息香酸及びそのエステル類ならびにそのアミド類など
が挙げられる。On the other hand, as the substituted benzaldehyde (I [I), 0-methoxybenzaldehyde, m-methoxybenzaldehyde, p-methoxybenzaldehyde, 2,3-dimethoxybenzaldehyde, 2.4-dimethoxybenzaldehyde, 3,4-dimethoxybenzaldehyde, 3,4 .5
-) Dimethoxybenzaldehyde, 3,4-methylenedioxybenzaldehyde, 0-hydroxybenzaldehyde, m-hydroxybenzaldehyde, p-hydroxybenzaldehyde, 0-formylbenzoic acid and its esters and its amides, m-formylbenzoic acid and its esters and amides thereof, p-formylbenzoic acid and esters thereof, and amides thereof.
本反応は、メタノール、エタノール、イソプロパツール
等のプロトン性溶媒、又はベンゼン、トルエン、キシレ
ン、テトラヒドロフラン等の非プロトン性溶媒中、塩基
を触媒として用い、20〜150℃で数十分〜数十時間
行うのが好ましい。ここで用いられる塩基としては、ナ
トリウムメトキシド、ナトリウムエトキシド、カリウム
−t−ブトキシドのような金属アルコキシド化合物;水
酸化ナトリウム、水酸化カリウムのような金属水酸化物
などが挙げられる。This reaction is carried out in a protic solvent such as methanol, ethanol, isopropanol, or an aprotic solvent such as benzene, toluene, xylene, or tetrahydrofuran, using a base as a catalyst at 20 to 150°C for several tens of tens of minutes. It is preferable to do it for an hour. Examples of the base used here include metal alkoxide compounds such as sodium methoxide, sodium ethoxide, and potassium t-butoxide; metal hydroxides such as sodium hydroxide and potassium hydroxide.
かくして得られるα−ベンジリデンケトン誘導体(1)
を含有する本発明紫外線吸収剤は、これらのα−ベンジ
リデンケトン誘導体(1)の1種あるいは2種以上をそ
のまま使用してもよいが、担体に加えて混和せしめた形
態のものが好ましい。α-Benzylidene ketone derivative (1) thus obtained
In the ultraviolet absorber of the present invention containing α-benzylidene ketone derivatives (1), one or more of these α-benzylidene ketone derivatives (1) may be used as they are, but it is preferable that they be mixed in addition to a carrier.
担体は上記α−ベンジリデンケトン誘導体(1)に対し
て不活性なものであればよく、固体、液体、乳剤、泡状
体、ゲル等のいずれであってもよい。The carrier may be any carrier as long as it is inert to the α-benzylidene ketone derivative (1), and may be solid, liquid, emulsion, foam, gel, or the like.
その代表的なものとしては、例えば水、アルコール、油
脂(例えば炭化水素オイル、脂肪酸エステル、長鎖アル
コール、シリコーン油)、澱粉又はタルク等の微粉末、
エアゾール噴射剤として使用される低沸点炭化水素又は
ハロゲン化炭化水素等が挙げられる。本発明の紫外線吸
収剤には、更に本発明α−ベンジリデンケトン誘導体(
I)の紫外線吸収作用を損わない限りにおいて、他の成
分、一
例えば防腐剤、香料、着色料、界面活性剤等を添加配合
することができる。Typical examples include water, alcohol, fats and oils (e.g. hydrocarbon oil, fatty acid ester, long chain alcohol, silicone oil), fine powder of starch or talc, etc.
Examples include low-boiling hydrocarbons or halogenated hydrocarbons used as aerosol propellants. The ultraviolet absorber of the present invention further includes the α-benzylidene ketone derivative of the present invention (
Other ingredients such as preservatives, fragrances, colorants, surfactants, etc. may be added as long as they do not impair the ultraviolet absorbing effect of I).
α−ベンジリデンケトン誘導体(I)を含有する化粧料
(以下、「本発明化粧料」と称する)は、その化粧料基
剤に対して親和性を有するα−ベンジリデンケトン誘導
体(1)の1種又は2種以上を適宜選択し、これを常法
により公知の化粧料基剤に配合し、クリーム、溶液、油
剤、スプレースティック、乳液、ファンデーション、軟
膏等の剤型にすることにより調製される。The cosmetic containing the α-benzylidene ketone derivative (I) (hereinafter referred to as the "cosmetic of the present invention") is one type of α-benzylidene ketone derivative (1) that has an affinity for the cosmetic base. Or, it can be prepared by selecting two or more of them as appropriate and blending them into a known cosmetic base by a conventional method to form a dosage form such as a cream, solution, oil, spray stick, milky lotion, foundation, or ointment.
すなわち、α−ベンジリデンケトン誘導体(1)を化粧
料基剤に合わせて選択使用することにより、オイル基剤
の化粧油、多量にオイルを配合する油性クリームや油性
乳液、水を多量に配合する弱油性クリームや弱油性乳液
、水ベースの化粧水等の基礎化粧品から油剤を基剤とす
るファンデーションやリップスティック等のメイクアッ
プ化粧料に至るまで、Uv吸収作用を有するあらゆる形
態の化粧品を製造することができる。これに適した基剤
及び溶剤としては、固体あるいは液状パラフイン、クリ
スタルオイル、セレシン、オシケライト又はモンタンろ
うなどの炭化水素類;オリーブ、地ろう、カルナウバろ
う、ラノリン又は鯨ろうなどの植物油若しくは動物性油
脂やろう;更にステアリン酸、パルミチン酸、オレイン
酸、グリセリンモノステアリン酸エステル、グリセリン
ジステアリン酸エステル、グリセリンモノオレイン酸エ
ステル、イソプロピルミリスチン酸エステル、イソプロ
ピルステアリン酸エステル又はブチルステアリン酸エス
テル等の脂肪酸及びそのエステル類;エチルアルコール
、イソプロピルアルコール、七チルアルコール、ステア
リルアルコール、パルミチルアルコール又はヘキシルド
デシルアルコール等のアルコール類などが挙げられる。That is, by selectively using the α-benzylidene ketone derivative (1) in accordance with the cosmetic base, oil-based cosmetic oils, oil-based creams and emulsions that contain a large amount of oil, and weak oil-based cosmetics that contain a large amount of water can be used. Manufacture all types of cosmetics that have UV absorption properties, from basic cosmetics such as oil-based creams, weak oil-based emulsions, and water-based lotions to makeup cosmetics such as oil-based foundations and lipsticks. I can do it. Suitable bases and solvents for this include hydrocarbons, such as solid or liquid paraffin, crystal oil, ceresin, osichelite or montan wax; vegetable or animal fats, such as olive, earth wax, carnauba wax, lanolin or spermaceti. Furthermore, fatty acids and their esters such as stearic acid, palmitic acid, oleic acid, glycerin monostearate, glycerin distearate, glycerin monooleate, isopropyl myristate, isopropyl stearate or butyl stearate; Examples include alcohols such as ethyl alcohol, isopropyl alcohol, heptyl alcohol, stearyl alcohol, palmityl alcohol, and hexyldodecyl alcohol.
また、グリコール、グリセリン又はソルビトールなどの
保湿作用を有する多価アルコール類も使用することがで
きる。Further, polyhydric alcohols having a moisturizing effect such as glycol, glycerin or sorbitol can also be used.
本発明紫外線吸収剤及び化粧料中のα−ベンジリデンケ
トン誘導体の配合量は、使用形態により変動し得るので
特に限定されず、有効量存在すればよいが、一般には粗
生成物中に0.1〜20重量%、好ましくは0.5〜1
0重量%となるように配合するのがよい。The amount of the α-benzylidene ketone derivative in the ultraviolet absorber and cosmetics of the present invention is not particularly limited as it may vary depending on the form of use, and it is sufficient that it is present in an effective amount, but generally 0.1% in the crude product. ~20% by weight, preferably 0.5-1
It is preferable to mix it so that it is 0% by weight.
本発明紫外線吸収剤及び化粧料はα−ベンジリデンケト
ン誘導体を配合したのみでもよいが、更に他のUV−8
吸収剤あるいはuv−へ吸収剤と組み合わせて、通常の
日焼は止め化粧料として使用するのがより好ましい。こ
のようなuv−e吸収剤としては、例えばp−メチルベ
ンジリデン−D、L−ショウノウ又はそのスルホン酸ナ
トリウム塩;2−フェニルベンズイミダゾール−5−ス
ルホン酸ナトリウム塩、3.4−ジメチルフェニルグリ
オキシル酸ナトリウム塩、4−フェニルベンゾフェノン
、4−フェニルベンゾフェノン−2′−カルボン酸イソ
オクチルエステル、p−メトキシ桂皮酸エステル、2−
フェニル−5−メチルベンズオキサゾール又はp−ジメ
チルアミノ安息香酸エステル類などが挙げられる。II
V−A吸収剤としては4−メトキシ−2′−カルボキシ
ジベンゾイルメタン、4−メトキシ−4′−t−ブチル
ジベンゾイルメタン、4イソプロピルジベンゾイルメタ
ン、2−ヒドロキシ−4−メトキシベンゾフェノン又は
ジベンジリデンカンファー類などが挙げられる。The UV absorbers and cosmetics of the present invention may contain only α-benzylidene ketone derivatives, but may also contain other UV-8
It is more preferable to use it as an ordinary sunscreen cosmetic in combination with an absorbent or UV absorber. Examples of such UV-e absorbers include p-methylbenzylidene-D, L-camphor or its sulfonic acid sodium salt; 2-phenylbenzimidazole-5-sulfonic acid sodium salt, 3.4-dimethylphenylglyoxylic acid. Sodium salt, 4-phenylbenzophenone, 4-phenylbenzophenone-2'-carboxylic acid isooctyl ester, p-methoxycinnamic acid ester, 2-
Examples include phenyl-5-methylbenzoxazole and p-dimethylaminobenzoic acid esters. II
As a VA absorbent, 4-methoxy-2'-carboxydibenzoylmethane, 4-methoxy-4'-t-butyldibenzoylmethane, 4isopropyldibenzoylmethane, 2-hydroxy-4-methoxybenzophenone or dibenzylidene is used. Examples include camphor.
本発明化粧料には、上記成分のほか、種々の添加剤を加
えることができる。適当な添加剤としては、例えばll
l10及びO/l’l型の乳化剤が挙げられる。In addition to the above-mentioned components, various additives can be added to the cosmetic composition of the present invention. Suitable additives include, for example,
Emulsifiers of the 110 and O/1'1 types may be mentioned.
乳化剤としては、市販の乳化剤が使用できる。またメチ
ルセルロース、エチルセルロース又はカルボキシメチル
セルロース、ポリアクリル酸、トラガカント、寒天又は
ゼラチン等の増粘剤も添加剤として加えることができる
。更に、必要に応じて、香料、防腐剤、保湿剤、乳化安
定剤、薬効成分及び/又は生理的に許容し得る着色剤を
添加してもよい。As the emulsifier, commercially available emulsifiers can be used. Thickeners such as methylcellulose, ethylcellulose or carboxymethylcellulose, polyacrylic acid, tragacanth, agar or gelatin can also be added as additives. Furthermore, fragrances, preservatives, humectants, emulsion stabilizers, medicinal ingredients, and/or physiologically acceptable colorants may be added as necessary.
〔実施例]
本発明について試験例及び実施例を挙げて更に具体的に
説明する。[Example] The present invention will be described in more detail by giving test examples and examples.
2 一
実施例1
2−(4−メトキシベンジリデン)インダン1−オンし
一般式(1)でR=−OCR,、n=IX=−CL−で
表わされる化合物](Ia)の合成:攪拌装置、還流冷
却器及び窒素導入管を備えた100mj!三ツロフラス
コ中、1−インダノン2.0g(15,1mm01)、
p−メトキシヘンステルテヒト2J g (16,9m
moA)をエタノール50 mlに溶解し、ここに水酸
化カリウム0.3g (4,54mmoIl)を加え室
温、窒素気流下に2時間攪拌、反応させる。析出した結
晶を濾取し、メタノールで洗浄することにより得た淡黄
色結晶をエタノールから再結晶して淡黄色針状晶の目的
物3.5gを得た。収率92.6%。2 Example 1 Synthesis of 2-(4-methoxybenzylidene)indan-1-one compound (Ia) represented by R=-OCR, n=IX=-CL- in the general formula (1): Stirring device , 100 mj with reflux condenser and nitrogen inlet tube! In the Mitsuro flask, 1-indanone 2.0g (15.1mm01),
p-Methoxyhensteltecht 2J g (16,9m
moA) was dissolved in 50 ml of ethanol, 0.3 g (4.54 mmol) of potassium hydroxide was added thereto, and the mixture was stirred and reacted at room temperature under a nitrogen stream for 2 hours. The precipitated crystals were collected by filtration, and the pale yellow crystals obtained by washing with methanol were recrystallized from ethanol to obtain 3.5 g of the desired product in the form of pale yellow needle crystals. Yield 92.6%.
mp、 139〜140℃
IRニジMmr1696.162B、 1604.15
18.1260゜1186 cm−’
’H−NMR: δ (CDCj! 3) 3
.87(311,s)、 4.0N2H,s)。mp, 139-140℃ IR Niji Mmr1696.162B, 1604.15
18.1260°1186 cm-''H-NMR: δ (CDCj! 3) 3
.. 87 (311, s), 4.0N2H, s).
6.98(2H,d、 8.8Hz)、 7.42(l
tl、 t、 7.5Hz)。6.98 (2H, d, 8.8Hz), 7.42 (l
tl, t, 7.5Hz).
7.5〜7.7(3H,m)、 7.65(2H,d、
8.8Hz)7、90 (LH,d、 7.6Hz
)実施例2
2−(4−カルボキシベンジリデン)インダン−1−オ
ン〔−船人(I)でR−−CO2fl、 n=IX−−
C)12−で表わされる化合物)(Ib)の合成:攪拌
装置、滴下漏斗、還流冷却器及び窒素導入管を備えた1
00mj!三ツロフラスコ中、4−カルボキシベンズア
ルデヒド2.27g (15,1mmojりをKO)I
1.1g (16,7mmojりのエタノール10
mj!と水5 mj!との混合溶媒に溶解し、室温下
撹拌する。7.5-7.7 (3H, m), 7.65 (2H, d,
8.8Hz)7,90 (LH,d, 7.6Hz
) Example 2 2-(4-carboxybenzylidene)indan-1-one [-R in Funato (I)--CO2fl, n=IX--
C) Synthesis of compound (Ib) represented by 12-: 1 equipped with a stirring device, a dropping funnel, a reflux condenser and a nitrogen inlet tube
00mj! In a Mitsuro flask, 2.27 g of 4-carboxybenzaldehyde (KO of 15.1 mm) I
1.1 g (16.7 mmoj ethanol 10
mj! and water 5 mj! Dissolve in a mixed solvent with and stir at room temperature.
ここに1−インダノン2.0g (15,1mmoj?
)のエタノール20m j!溶液を1時間かけて滴下後
、更に1時間攪拌を続け、析出した結晶を濾取する。得
られた結晶をクロロホルム20mj!に懸濁し、2NH
C1で中和後、結晶を濾取し、エタノールから再結晶し
て淡黄色粉末の目的物1.5gを得た。収率37.6%
。Here is 2.0g of 1-indanone (15.1mmoj?
) of ethanol 20m j! After the solution was added dropwise over 1 hour, stirring was continued for another 1 hour, and the precipitated crystals were collected by filtration. The obtained crystals were immersed in 20mj of chloroform! Suspended in 2NH
After neutralization with C1, the crystals were collected by filtration and recrystallized from ethanol to obtain 1.5 g of the desired product as a pale yellow powder. Yield 37.6%
.
IRニジ、、、 3000〜2500br、 169
9.1676、162g。IR Niji, 3000~2500br, 169
9.1676, 162g.
1325、1299.766、728 am’)l−
NMR:δ(CDCJ! −+ DMSO−d、)
4. lN2H,s)。1325, 1299.766, 728 am')l-
NMR: δ(CDCJ!-+DMSO-d,)
4. lN2H,s).
7.4〜7.8(4H,m)、 7.74(2H,d
、 8.4Hz)7.90(LH,d、 ?、5t
lz)、 8.13(2H,d、 8.3flz)
実施例3
2− (2−ヒドロキシベンジリデン)インダン−1−
オン〔−船人(I)でR−1叶、n=1゜X=−CH2
−で表わされる化合物:I(Ic)の合成=1−インダ
ノン 1.0g (7,57mmoA) 、サリチルア
ルデヒド1.0g (8,19mmoffl) 、水酸
化カリウム0.9g (13,6mmoj! ) 、x
タノール30mj?を用い、実施例1と同様の方法で2
0時間反応し、黄色粒状晶の目的物0.85gを得た。7.4-7.8 (4H, m), 7.74 (2H, d
, 8.4Hz) 7.90 (LH, d, ?, 5t
lz), 8.13 (2H, d, 8.3flz)
Example 3 2-(2-hydroxybenzylidene)indan-1-
On [-Sailor (I) with R-1 leaf, n=1゜X=-CH2
- Synthesis of compound I (Ic) = 1-indanone 1.0 g (7,57 mmoA), salicylaldehyde 1.0 g (8,19 mmoffl), potassium hydroxide 0.9 g (13,6 mmoj!), x
Tanol 30mj? 2 in the same manner as in Example 1 using
The reaction was carried out for 0 hours, and 0.85 g of the target product in the form of yellow granular crystals was obtained.
収率47.5%。Yield 47.5%.
融点 168℃(分解)
IRニジllBr 3220.166B、 1599
.1455.1359゜1332、1305.1257
.1236.1125゜747、732
’H−NMR: δ (CDoOD+DMSO−d、
) 4.04(2H,s)。Melting point 168℃ (decomposition) IR NijillBr 3220.166B, 1599
.. 1455.1359゜1332, 1305.1257
.. 1236.1125°747,732'H-NMR: δ (CDoOD+DMSO-d,
) 4.04 (2H, s).
6.8〜8.2(9H,m)
実施例4
2−(4−メトキシベンジリデン) −1,2,3,4
−テトラヒドロナフタレン−1−オン〔−船人%式%
表わされる化合物)(Id)の合成・
1−テトラロン2.0g (13,7mmoJ2 )
、p−メトキシベンズアルデヒド2.Og (14,7
mmoJ>、水酸化カリウム28mg (0,42mm
oj! )及びエタノール2Q+r+1を用い、実施例
1と同様の方法で3時間反応し、淡黄色結晶の目的物1
.5gを得た。収率41.4%。6.8-8.2 (9H, m) Example 4 2-(4-methoxybenzylidene) -1,2,3,4
Synthesis of -tetrahydronaphthalen-1-one [-Shipin% formula% compound] (Id) 1-tetralone 2.0g (13,7mmoJ2)
, p-methoxybenzaldehyde2. Og (14,7
mmoJ>, potassium hydroxide 28 mg (0,42 mm
oj! ) and ethanol 2Q+r+1 in the same manner as in Example 1 for 3 hours to obtain the desired product 1 as pale yellow crystals.
.. 5g was obtained. Yield 41.4%.
’H−NMR: δ (C[lC(l a)
2.94 <2tl、 t、 5.81(z)
。'H-NMR: δ(C[lC(l a)
2.94 <2tl, t, 5.81(z)
.
3.15(2H,t、 5.8Hz)、 3.85(3
ft、 s)。3.15 (2H, t, 5.8Hz), 3.85 (3
ft, s).
6.9〜8.2 (9fl、 m)
実施例5
2−(4−カルボキシベンジリデン) −1,2,3゜
4−テトラヒドロナフタレン−1−オン〔−船人%式%
表わされる化合物)(Ie)の合成:
1−テトラロン2.0g (13,7mmoA) 、4
−カルボキシベンズアルデヒド(13,3mmol)
、水酸化カリウム1.1g (16,7mmojり 、
メタノール10mβと水5 mlとの混合溶媒及び更に
メタノール20mAを用い、実施例2と同様の方法で8
時間反応せしめ、淡黄色粉末の目的物1.0gを得た。6.9-8.2 (9fl, m) Example 5 2-(4-carboxybenzylidene) -1,2,3゜4-tetrahydronaphthalen-1-one [-Shipin% formula% compound represented by] ( Synthesis of Ie): 1-tetralone 2.0 g (13,7 mmoA), 4
-Carboxybenzaldehyde (13.3 mmol)
, potassium hydroxide 1.1g (16.7mm),
8 in the same manner as in Example 2 using a mixed solvent of 10 mβ of methanol and 5 ml of water and 20 mA of methanol.
The reaction was allowed to proceed for a period of time to obtain 1.0 g of the desired product as a pale yellow powder.
収率 26.2%。Yield: 26.2%.
融点 220〜223℃
■R;シー5r3070〜2550br、 1689.
160g、 1426゜1296、1250 cm
−’
’H−NMR:δ(CDCj!、) 2.98(2H
,t)、 3.14(2H,t)。Melting point 220~223℃ ■R; Sea 5r 3070~2550br, 1689.
160g, 1426°1296, 1250cm
-''H-NMR: δ(CDCj!,) 2.98(2H
, t), 3.14 (2H, t).
7、2〜8.2 (9)1. m)
実施例6
6−(4−メトキシベンジリデン)ベンゾシクロへブタ
−5−オン〔−船人(I)でR=−OCIl、。7, 2-8.2 (9)1. m) Example 6 6-(4-Methoxybenzylidene)benzocyclohebut-5-one [-R=-OCIl in Shipin (I).
n=1.X −−CLCLCL−で表わされる化合物〕
(If)の合成:
1−ペンゾスベロン1.0g (6,24mmotl)
、TI)メトキシベンズアルデヒド (]、9g (
6,61mmoj! )、水酸化カリウム0.2g (
3,03mmo、&)及びエタノール15+nj!を用
い、実施例1と同様の方法で2時間反応せしめ、淡黄色
結晶の目的物1.1gを得た。n=1. Compound represented by X --CLCLCL-]
Synthesis of (If): 1-penzosuberone 1.0 g (6,24 mmotl)
, TI) methoxybenzaldehyde (], 9g (
6,61 mmoj! ), potassium hydroxide 0.2g (
3,03 mmo, &) and ethanol 15+nj! The mixture was reacted for 2 hours in the same manner as in Example 1 to obtain 1.1 g of the desired product as pale yellow crystals.
収率 64.3%。Yield: 64.3%.
’H−NMR:δ(CDCj!3) 2.08(2
H,Quint、 6.8Hz)2.63(2H,t、
6.8Hz)、 2.89(2fl、 t、
6.811z)3.85(3H,s)、 6.95
(2H,八B、 8.8)1z)7.50(2tl
AB、 8.8tlz)、 7.1〜7.9(
5N、 m)実施例7
2−(4−メトキシベンジリデン)インダン1.3−ジ
オン〔−船人(I)でR=−OCH3,nl、X−−C
o−で表わされる化合物:l (Ig)の合成:
1.3−インダンジオン2.0g (13,7mmoβ
)、4−メトキシベンズアルデヒド2.05g (15
,1mmop)、水酸化カリウム0.3g (4,54
mmojり及びエタノール50m1を用い、実施例1と
同様の方法で200時間反応しめ、黄色結晶の目的物1
.3gを得た。'H-NMR: δ(CDCj!3) 2.08(2
H, Quint, 6.8Hz) 2.63(2H,t,
6.8Hz), 2.89(2fl, t,
6.811z) 3.85 (3H, s), 6.95
(2H, 8B, 8.8) 1z) 7.50 (2tl
AB, 8.8tlz), 7.1~7.9(
5N, m) Example 7 2-(4-methoxybenzylidene) indane 1,3-dione [-Funenin (I), R=-OCH3, nl, X--C
Compound represented by o-: Synthesis of l (Ig): 2.0 g of 1,3-indanedione (13,7 mmoβ
), 4-methoxybenzaldehyde 2.05g (15
, 1mmop), potassium hydroxide 0.3g (4,54
A reaction was carried out for 200 hours in the same manner as in Example 1 using mmoj and 50 ml of ethanol to obtain the target product 1 as yellow crystals.
.. 3g was obtained.
収率 35.9%。Yield: 35.9%.
’)I−NMR:δ(CD[:A 、) 3゜92
(3)1. s) 、 7.02 (2H。') I-NMR: δ(CD[:A,) 3°92
(3)1. s), 7.02 (2H.
AB、 9.0Hz)、 7.7〜B、H2N、 m)
、 8.56(2H。AB, 9.0Hz), 7.7~B, H2N, m)
, 8.56 (2H.
AB、 9.0Hz)
実施例8
2−(4−カルポキシベンジリテ゛ン)インダン1.3
−ジオン〔−船人(I)でR−−CO2H,nl、X−
−Co−で表わされる化合物](Ih)の合成;
1.3−インダンジオン2.0g (13,7mmon
>、4−カルボキシベンズアルデヒド2.0g (1
3,3mmoj2)、水酸化カリウム1.2g (18
,2mmoA)、メタノール20m i!と水20m
j!との混合溶媒及び更にメタノール20m j!を用
い、実施例2と同様の方法で8時間反応し、淡黄色結晶
の目的物1.2gを得た。AB, 9.0Hz) Example 8 2-(4-carpoxybenzylene)indan 1.3
-Zion [-Seaman (I) and R--CO2H, nl, X-
Synthesis of compound represented by -Co- (Ih); 2.0 g (13,7 mmon) of 1,3-indanedione
>, 4-carboxybenzaldehyde 2.0g (1
3.3 mmoj2), potassium hydroxide 1.2 g (18
, 2mmoA), methanol 20m i! and water 20m
j! Mixed solvent with and further methanol 20m j! The mixture was reacted for 8 hours in the same manner as in Example 2 to obtain 1.2 g of the desired product in the form of pale yellow crystals.
収率 32.4%。Yield: 32.4%.
’)I−NMR: δ (CD、OD+口MSO−d
6) 7.9〜B、H5fl、 m)。') I-NMR: δ (CD, OD+MSO-d
6) 7.9~B, H5fl, m).
8.07(2L AB、 8.3Hz)、 8.53(
2H,AB、 8.4Hz)実施例9
3−(4−メトキシベンジリデン)クロマン4−オン〔
−船人(I)でR−QC)13. n = 1 。8.07 (2L AB, 8.3Hz), 8.53 (
2H,AB, 8.4Hz) Example 9 3-(4-methoxybenzylidene)chroman-4-one [
-Sailor (I) R-QC)13. n=1.
X = −0CI1.−で表わされる化合物](Ii)
の合成:攪拌装置、還流冷却器、ディーンースターク脱
水装置及び窒素導入管を備えた100+nj! 3ツロ
フラスコ中、4−クロマノン 1.0g (6,64m
moA )、p−メトキシベンズアルデヒド1.0g(
7,3相moj?)、ナトリウムメチラート 0.4g
(7,40mmoA )及びドライベンゼン50o+
j!を混合し、窒素気流下に2時間還流し、生成する水
を除去する。放冷後、2N塩酸で中和し、クロロホルム
で抽出する。溶液を硫酸マグネシウムで乾燥後、溶媒留
去し、得られた粗生成物をメタノールから再結晶して淡
黄色針状晶の目的物0.24gを得た。収率 13.6
%。X = -0CI1. - Compound] (Ii)
Synthesis: 100+nj! equipped with a stirrer, reflux condenser, Dean-Stark dehydrator and nitrogen inlet tube! 4-chromanone 1.0g (6.64m
moA), p-methoxybenzaldehyde 1.0g (
7.3 phase moj? ), sodium methylate 0.4g
(7,40mmoA) and dry benzene 50o+
j! The mixture was mixed and refluxed for 2 hours under a nitrogen stream to remove the water produced. After cooling, neutralize with 2N hydrochloric acid and extract with chloroform. After drying the solution over magnesium sulfate, the solvent was distilled off, and the resulting crude product was recrystallized from methanol to obtain 0.24 g of the desired product in the form of pale yellow needles. Yield 13.6
%.
融点 132〜133℃
IR;シMBr166B、 1610.1514.14
80.1468゜132B、 1312.1254.1
212.1030゜1016、754 cm ’
’11−NMR:δ(CDCβ3)3.87 (3H,
s) 、 5.38 (2H,d。Melting point 132-133℃ IR; ShiMBr166B, 1610.1514.14
80.1468°132B, 1312.1254.1
212.1030°1016,754 cm''11-NMR: δ(CDCβ3)3.87 (3H,
s), 5.38 (2H, d.
1.8Hz)、 6.97(2B、 八B、 8
.8Hz)、 7.29(2H。1.8Hz), 6.97 (2B, 8B, 8
.. 8Hz), 7.29 (2H.
AB、 8.8Hz)、 7.84(Ift、 br
s)、 7.0〜8.1(4fl、 m)
実施例10
3−(4−メトキシベンジリデン)−1,2,3,4テ
トラヒドロ−1−チアナフタレン−4−オン〔−船人(
I)でR−−OCH=、 n=1. X5C)I2−で
表わされる化合物:] (Ij)の合成:1−チオク
ロマン−4−オン1.0 g (6,09mmo fl
)、p−メトキシベンズアルデヒド0.9 g (6
,61mmo fl )、水酸化カリウム0.2g (
3,03mmoj2 )及びエタノール50m1を用い
、実施例1と同様の方法で5時間反応せしめ、淡黄色粉
末の目的物0.74gを得た。AB, 8.8Hz), 7.84(Ift, br
s), 7.0 to 8.1 (4fl, m) Example 10 3-(4-methoxybenzylidene)-1,2,3,4tetrahydro-1-thianaphthalen-4-one [-Funenin (
I) with R--OCH=, n=1. X5C) Compound represented by I2-: Synthesis of (Ij): 1-thiochroman-4-one 1.0 g (6,09 mmo fl
), p-methoxybenzaldehyde 0.9 g (6
, 61 mmof fl ), potassium hydroxide 0.2 g (
Using 3,03 mmoj2 ) and 50 ml of ethanol, the reaction was carried out in the same manner as in Example 1 for 5 hours to obtain 0.74 g of the desired product as a pale yellow powder.
収率 43.0%。Yield: 43.0%.
融点 114〜116℃
IRニジK11r1677、1653.1596.15
09.1443゜1302、1260.1212.11
79 c+n−’’H−NMR:δ(CDCj! 3
) 3.85(3H,s)、 4.15(2H,d。Melting point 114-116℃ IR Niji K11r1677, 1653.1596.15
09.1443°1302, 1260.1212.11
79 c+n-''H-NMR: δ(CDCj! 3
) 3.85 (3H, s), 4.15 (2H, d.
1.011z)、 6.96(2H,AB、 8.8H
z)、 7.38(2H。1.011z), 6.96 (2H, AB, 8.8H
z), 7.38 (2H.
八B、 8.8flz)、 7.75(IH,br
s)、 7.2〜7.5(411,m)
試験例1
本発明α−ベンジリデンケトン誘導体(I)の紫外線吸
収効果:
本発明のα−ベンジリデンケトン誘導体として前記実施
例で得た(I a)〜(I j)の化合物を用い、比較
化合物として、IIV−A吸収剤である2−ヒドロキシ
−4−メトキシベンゾフェノンを用い、紫外線吸収効果
(吸光度)、を下記方法により測定した。結果を表1に
示す。8B, 8.8flz), 7.75(IH, br
s), 7.2 to 7.5 (411, m) Test Example 1 Ultraviolet absorption effect of the α-benzylidene ketone derivative (I) of the present invention: As the α-benzylidene ketone derivative of the present invention (I Using the compounds of a) to (Ij) and 2-hydroxy-4-methoxybenzophenone, which is an IIV-A absorber, as a comparative compound, the ultraviolet absorption effect (absorbance) was measured by the method described below. The results are shown in Table 1.
(測定方法)
本発明化合物及び比較化合物の2.5X 10−5mo
j21fla度のエタノール(99,5%試薬特級)溶
液を調製し、石英セル(1cmx1cm)に入れた後、
日立製U = 3410形自記分光光度計により測定し
た。(Measurement method) 2.5X 10-5 mo of the present invention compound and comparative compound
After preparing a 21 fl degree ethanol (99.5% reagent special grade) solution and placing it in a quartz cell (1 cm x 1 cm),
Measurement was performed using a U=3410 type self-recording spectrophotometer manufactured by Hitachi.
以下余白
Ia:2−(4−メトキシベンジリデン)インダン−1
−オン
Ib:2−(4−カルボキシベンジリデン)インダン−
1−オン
Ic:2−(2−ヒドロキシベンジリデン)インダン−
1−オン
Id:2−(4−メトキシベンジリデン)−1,2゜3
4−テトラヒドロナフタレン−1−オンIe:2−(4
−カルボキシベンジリデン)−1,2゜3.4−テトラ
ヒドロナフタレン−1−オンIf:6−(4−メトキシ
ベンジリデン)ベンゾシクロへブタ−5−オン
Ig:2−(4−メトキシベンジリデン)インダン−1
,3−ジオン
Ih:2−(4−カルボキシベンジリデン)インダン−
1,3−ジオン
Ii:3−(4−メトキシベンジリデン)クロマン−4
−オン
Ij:3−(4−メトキシベンジリデン)−1,2゜3
.4−テトラヒドロ−1−チアナフタレン4−オン
比較化合物1:2−ヒドロキシ−4−メトキシベンゾフ
ェノン
これらの結果は、本発明α−ベンジリデンケトン誘導体
がIIV−A紫外線に対して、比較化合物2−ヒドロキ
シー4−メトキシベンゾフェノンより吸収効果が強く、
日焼は止め効果の高い事を示している。Below margin Ia: 2-(4-methoxybenzylidene)indan-1
-one Ib: 2-(4-carboxybenzylidene)indan-
1-one Ic: 2-(2-hydroxybenzylidene)indan-
1-one Id: 2-(4-methoxybenzylidene)-1,2゜3
4-tetrahydronaphthalen-1-one Ie:2-(4
-carboxybenzylidene)-1,2゜3.4-tetrahydronaphthalen-1-one If: 6-(4-methoxybenzylidene)benzocyclohebut-5-one Ig: 2-(4-methoxybenzylidene) indan-1
,3-dione Ih:2-(4-carboxybenzylidene)indan-
1,3-dione Ii: 3-(4-methoxybenzylidene)chroman-4
-one Ij: 3-(4-methoxybenzylidene)-1,2゜3
.. 4-tetrahydro-1-thianaphthalene 4-one Comparative compound 1: 2-hydroxy-4-methoxybenzophenone - Stronger absorption effect than methoxybenzophenone,
It has been shown to have a high sun protection effect.
試験例2
本発明α−ベンジリデンケトン誘導体の紫外線に対する
安定性:
前記実施例で得た(I a)〜(I j)の化合物を用
い、比較化合物として4−メトキシ−4′t−ブチルジ
ベンゾイルメタンを用い、紫外線に対する安定性を下記
実験方法により試験した。結果を表2に示す。Test Example 2 Stability of the α-benzylidene ketone derivative of the present invention against ultraviolet light: Using the compounds (I a) to (I j) obtained in the above examples, 4-methoxy-4't-butyldibenzoyl was used as a comparative compound. Using methane, stability against ultraviolet light was tested by the following experimental method. The results are shown in Table 2.
(実験方法)
99.5%エタノール/蒸留水(3/2)溶媒中、本発
明化合物並びに比較化合物を2mmoj2/βになるよ
うに溶解し、太陽光に極狛で近似の波長及び強度を有す
るキセノン針元試験機を用いて14時間紫外線を照射し
た。溶媒を留去後、定量分析を行い残存率から安定性を
評価した。結果を表2に示す。(Experimental method) The compound of the present invention and the comparative compound were dissolved in a solvent of 99.5% ethanol/distilled water (3/2) to a concentration of 2 mmoj2/β, which had a wavelength and intensity very close to sunlight. Ultraviolet rays were irradiated for 14 hours using a xenon needle tester. After distilling off the solvent, quantitative analysis was performed and stability was evaluated from the residual rate. The results are shown in Table 2.
表2 光安定性評価
ジベンゾイルメタン
表2の結果より、UV−A吸収剤として汎用されている
4−メトキシ−4’ −t−ブチルジベンゾイルメタン
と比較し、本発明化合物は紫外線に対して安定性が優れ
ていることが明らかである。Table 2 Photostability evaluation of dibenzoylmethane From the results in Table 2, compared to 4-methoxy-4'-t-butyldibenzoylmethane, which is commonly used as a UV-A absorber, the compounds of the present invention are more resistant to ultraviolet rays. It is clear that the stability is excellent.
実施例11
0/W型クリーム
下記組成を常法に従って配合し、O/W型クリームを調
製した。Example 11 O/W type cream The following composition was blended according to a conventional method to prepare an O/W type cream.
* 4 メトキシ 4′ −t−ブチル 本発明化合物(I a) ステアリン酸 親油型モノステアリン酸グリセリド ポリオキシエチレンソルビタンモノ ステアレート 七チルアルコール ステアリルアルコール スクワラン 流動パラフィン 1.0 1.0 20.0 ワセリン ブチルパラベン メチルパラベン トリエタノールアミン グリセリン 香 料 水 実施例12 W10型クリーム: 下記組成を常法に従って配合し、 −ムを調製した。 *4 methoxy 4′ -t-butyl Compound of the present invention (Ia) stearic acid Lipophilic monostearic acid glyceride polyoxyethylene sorbitan mono stearate Heptyl alcohol stearyl alcohol Squalane liquid paraffin 1.0 1.0 20.0 Vaseline butyl paraben Methylparaben triethanolamine glycerin Incense fee water Example 12 W10 type cream: Mix the following composition according to the usual method, - A sample was prepared.
本発明化合物(I b)
ソルビタンセスキオレエート
ステアリン酸アルミニウム
セチルアルコール
流動パラフィン
スクワラン
5.0
0.1
0.1
1.0
10.0
適 量
バランス
100、0
W10型ク
リ
(重量%)
2.0
4.0
0.5
4.0
16.0
10.0
ミリスチン酸イソプロピル
安息香酸ナトリウム
グリセリン
香 料
水
0.3
10.0
適 量
バランス
100、0
実施例13
0/W型乳液:
下記組成を常法に従って配合し、○/W型乳液を調製し
た。Compound of the present invention (Ib) Sorbitan sesquioleate Aluminum stearate Cetyl alcohol Liquid paraffin Squalane 5.0 0.1 0.1 1.0 10.0 Appropriate amount Balance 100, 0 W10 type chestnut (wt%) 2.0 4.0 0.5 4.0 16.0 10.0 Sodium myristate isopropyl benzoate Glycerin flavored water 0.3 10.0 Appropriate amount balance 100,0 Example 13 0/W type emulsion: The following composition was A ○/W type emulsion was prepared by blending according to the method.
本発明化合物(I c) ステアリン酸 モノステアリン酸ソルビタン モノステアリン酸ポリオキシ エチレンソルビタン セチルアルコール ステアリルアルコール ミリスチン酸イソプロピル 0.4 7.0 スクワラン 流動パラフィン 固形パラフィン エチルパラベン メチルパラベン カーボボール 苛性カリ 香 料 水 5.0 5.0 2.0 0.1 0.1 0.2 0.4 適量 バランス ioo、 。 Compound of the present invention (Ic) stearic acid Sorbitan monostearate Polyoxy monostearate ethylene sorbitan cetyl alcohol stearyl alcohol Isopropyl myristate 0.4 7.0 Squalane liquid paraffin solid paraffin ethylparaben Methylparaben carbo balls caustic potash Incense water 5.0 5.0 2.0 0.1 0.1 0.2 0.4 Appropriate amount balance ioo,.
実施例14 化粧水: 下記組成を常法に従って配合し、化粧水を調製した。Example 14 Lotion: A lotion was prepared by blending the following composition according to a conventional method.
本発明化合物(I d)
ポリオキシエチレン(23)ラウリル
エーテル
エタノール
(重量%)
2.0
4.0
10、0
グリセリン 3.0ジプロピレ
ングリコール 7.0乳 酸
005乳酸ナ
トリウム 0.12メチルパラ
ベン 0.1香 料
適 景色
素 微
量水 バラ″1
00、0
〔発明の効果〕
本発明のα−ベンジリデンケトン誘導体(I)は優れた
紫外線吸収作用と卓越した安定性を有するため、これを
配合した紫外線吸収剤又は化粧料は日焼は防止効果に優
れたものである。Compound of the present invention (I d) Polyoxyethylene (23) lauryl ether ethanol (wt%) 2.0 4.0 10,0 Glycerin 3.0 Dipropylene glycol 7.0 Lactic acid
005 Sodium lactate 0.12 Methylparaben 0.1 Fragrance
suitable scenery
elementary minute
Quantity water rose ″1
00,0 [Effect of the invention] Since the α-benzylidene ketone derivative (I) of the present invention has excellent ultraviolet absorbing action and excellent stability, ultraviolet absorbers or cosmetics containing it have a sunburn prevention effect. It is excellent.
以上that's all
Claims (1)
ぞれ水酸基、アルコキシ基、アルケニルオキシ基、アラ
ルキルオキシ基、カルボキシル基、アルコキシカルボニ
ル基又はアミノカルボニル基を示すか、又は2個のRで
α−メチレン−ジオキシ基を形成してもよい。 nは1〜3の整数を示し、Xは炭素数1〜3のアルキレ
ン基、カルボニル基、酸素原子、硫黄原子、炭素数1〜
2のオキシアルキレン基又は炭素数1〜2のチオアルキ
レン基を示す) で表わされるα−ベンジリデンケトン誘導体。 2、請求項1記載のα−ベンジリデンケトン誘導体を含
有することを特徴とする紫外線吸収剤。 3、請求項1記載のα−ベンジリデンケトン誘導体を含
有することを特徴とする化粧料。[Claims] 1. The following general formula (I) ▲There are mathematical formulas, chemical formulas, tables, etc.▼(I) (In the formula, n R's may be the same or different, and each represents a hydroxyl group or an alkoxy group. , an alkenyloxy group, an aralkyloxy group, a carboxyl group, an alkoxycarbonyl group or an aminocarbonyl group, or two R's may form an α-methylene-dioxy group. n is an integer of 1 to 3. X is an alkylene group having 1 to 3 carbon atoms, a carbonyl group, an oxygen atom, a sulfur atom, or an alkylene group having 1 to 3 carbon atoms.
2 oxyalkylene group or thioalkylene group having 1 to 2 carbon atoms). 2. An ultraviolet absorber containing the α-benzylidene ketone derivative according to claim 1. 3. A cosmetic containing the α-benzylidene ketone derivative according to claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP25473890A JPH04134043A (en) | 1990-09-25 | 1990-09-25 | New alpha-benzylidene ketone derivative, ultraviolet absorber and cosmetic containing said absorber |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP25473890A JPH04134043A (en) | 1990-09-25 | 1990-09-25 | New alpha-benzylidene ketone derivative, ultraviolet absorber and cosmetic containing said absorber |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04134043A true JPH04134043A (en) | 1992-05-07 |
Family
ID=17269176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP25473890A Pending JPH04134043A (en) | 1990-09-25 | 1990-09-25 | New alpha-benzylidene ketone derivative, ultraviolet absorber and cosmetic containing said absorber |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04134043A (en) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0823418A3 (en) * | 1996-08-07 | 1998-04-29 | Haarmann & Reimer Gmbh | Indanylidene derivatives, process for their preparation and their use as UV-absorbers |
EP1039897A4 (en) * | 1997-11-17 | 2002-10-02 | Univ California | Inadone and tetralone compounds for inhibiting cell proliferation |
WO2007128723A1 (en) * | 2006-05-03 | 2007-11-15 | Symrise Gmbh & Co. Kg | Ah receptor antagonists |
JP2009084220A (en) * | 2007-09-28 | 2009-04-23 | Fujifilm Corp | New polymerizable compound |
EP2404595A3 (en) * | 2011-09-01 | 2012-03-07 | Symrise AG | Method for manufacturing indanone derivatives |
EP2238968A3 (en) * | 2009-04-06 | 2013-06-05 | Henkel AG & Co. KGaA | Skin treatment fighting skin aging |
EP2238967A3 (en) * | 2009-04-06 | 2013-06-05 | Henkel AG & Co. KGaA | Skin treatment fighting skin aging II |
WO2014010099A1 (en) | 2012-07-13 | 2014-01-16 | L'oreal | Composite pigment and method for preparing the same |
WO2014009097A1 (en) | 2012-07-13 | 2014-01-16 | L'oreal | Cosmetic composition containing screening composite particles |
WO2016030839A1 (en) | 2014-08-28 | 2016-03-03 | L'oreal | Gel composition and gel comprising a uv filter |
WO2016083404A1 (en) | 2014-11-24 | 2016-06-02 | L'oreal | Cosmetic composition comprising a synthetic phyllosilicate and a polyol and/or a uv filter |
WO2016198581A1 (en) | 2015-06-11 | 2016-12-15 | L'oreal | Composition comprising a uv-screening agent, an anionic crosslinked hydrophilic polymer, a surfactant having an hlb less than or equal to 5 and a silicone copolymer |
WO2019096960A1 (en) | 2017-11-15 | 2019-05-23 | L'oreal | Compositions comprising at least one acrylic polymer and at least one insoluble organic screening agent |
CN109851571A (en) * | 2019-01-21 | 2019-06-07 | 浙江大学 | A kind of organic photovoltaic cell being conjugated small organic molecule modifying interface material, preparation method and its composition |
FR3083093A1 (en) | 2018-06-28 | 2020-01-03 | L'oreal | PHOTOPROTECTOR COMPOSITION COMPRISING COLLOIDAL SILICA PARTICLES |
FR3090329A1 (en) | 2018-12-21 | 2020-06-26 | L'oreal | Composition comprising a UV filter, an anionic crosslinked hydrophilic polymer, a surfactant having an HLB less than or equal to 5 and a non-volatile alkane |
FR3103705A1 (en) | 2019-11-29 | 2021-06-04 | L'oreal | A composition comprising a UV filter, a block polymer containing a phosphonic acid group and a hydrocarbon oil |
FR3103704A1 (en) | 2019-11-29 | 2021-06-04 | L'oreal | Composition comprising a UV filter, an ethylenic polymer with a phosphonic acid group and a hydrocarbon oil |
US11266584B2 (en) | 2012-07-13 | 2022-03-08 | L'oreal | Cosmetic composition comprising composite sunscreen particles |
US11523976B2 (en) | 2012-07-13 | 2022-12-13 | L'oreal | Composite pigment and method for preparing the same |
-
1990
- 1990-09-25 JP JP25473890A patent/JPH04134043A/en active Pending
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0823418A3 (en) * | 1996-08-07 | 1998-04-29 | Haarmann & Reimer Gmbh | Indanylidene derivatives, process for their preparation and their use as UV-absorbers |
US5965066A (en) * | 1996-08-07 | 1999-10-12 | Haarmann & Reimer Gmbh | Indanylidene compounds, a process for their preparation and their use as UV absorbers |
US6153175A (en) * | 1996-08-07 | 2000-11-28 | Haarmann & Reimer Gmbh | Indanylidene compounds, a process for their preparation and their use as UV absorbers |
EP1039897A4 (en) * | 1997-11-17 | 2002-10-02 | Univ California | Inadone and tetralone compounds for inhibiting cell proliferation |
WO2007128723A1 (en) * | 2006-05-03 | 2007-11-15 | Symrise Gmbh & Co. Kg | Ah receptor antagonists |
JP2009536933A (en) * | 2006-05-03 | 2009-10-22 | シムライズ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニー・コマンジツト・ゲゼルシヤフト | Ah receptor antagonist |
US7855310B2 (en) | 2006-05-03 | 2010-12-21 | Symrise Gmbh & Co. Kg | AH receptor antagonists |
JP2009084220A (en) * | 2007-09-28 | 2009-04-23 | Fujifilm Corp | New polymerizable compound |
EP2238968A3 (en) * | 2009-04-06 | 2013-06-05 | Henkel AG & Co. KGaA | Skin treatment fighting skin aging |
EP2238967A3 (en) * | 2009-04-06 | 2013-06-05 | Henkel AG & Co. KGaA | Skin treatment fighting skin aging II |
EP2404595A3 (en) * | 2011-09-01 | 2012-03-07 | Symrise AG | Method for manufacturing indanone derivatives |
WO2014009097A1 (en) | 2012-07-13 | 2014-01-16 | L'oreal | Cosmetic composition containing screening composite particles |
WO2014010099A1 (en) | 2012-07-13 | 2014-01-16 | L'oreal | Composite pigment and method for preparing the same |
US11266584B2 (en) | 2012-07-13 | 2022-03-08 | L'oreal | Cosmetic composition comprising composite sunscreen particles |
US11523976B2 (en) | 2012-07-13 | 2022-12-13 | L'oreal | Composite pigment and method for preparing the same |
WO2016030839A1 (en) | 2014-08-28 | 2016-03-03 | L'oreal | Gel composition and gel comprising a uv filter |
WO2016083404A1 (en) | 2014-11-24 | 2016-06-02 | L'oreal | Cosmetic composition comprising a synthetic phyllosilicate and a polyol and/or a uv filter |
WO2016198581A1 (en) | 2015-06-11 | 2016-12-15 | L'oreal | Composition comprising a uv-screening agent, an anionic crosslinked hydrophilic polymer, a surfactant having an hlb less than or equal to 5 and a silicone copolymer |
WO2019096960A1 (en) | 2017-11-15 | 2019-05-23 | L'oreal | Compositions comprising at least one acrylic polymer and at least one insoluble organic screening agent |
FR3083093A1 (en) | 2018-06-28 | 2020-01-03 | L'oreal | PHOTOPROTECTOR COMPOSITION COMPRISING COLLOIDAL SILICA PARTICLES |
FR3090329A1 (en) | 2018-12-21 | 2020-06-26 | L'oreal | Composition comprising a UV filter, an anionic crosslinked hydrophilic polymer, a surfactant having an HLB less than or equal to 5 and a non-volatile alkane |
CN109851571A (en) * | 2019-01-21 | 2019-06-07 | 浙江大学 | A kind of organic photovoltaic cell being conjugated small organic molecule modifying interface material, preparation method and its composition |
FR3103705A1 (en) | 2019-11-29 | 2021-06-04 | L'oreal | A composition comprising a UV filter, a block polymer containing a phosphonic acid group and a hydrocarbon oil |
FR3103704A1 (en) | 2019-11-29 | 2021-06-04 | L'oreal | Composition comprising a UV filter, an ethylenic polymer with a phosphonic acid group and a hydrocarbon oil |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH04134043A (en) | New alpha-benzylidene ketone derivative, ultraviolet absorber and cosmetic containing said absorber | |
EP0255157B1 (en) | Novel sunscreen agents, sunscreen compositions and methods for preventing sunburn | |
US4584190A (en) | Novel chalcone derivatives and ultraviolet absorbers comprising the same | |
AT391687B (en) | METHOD FOR PRODUCING NEW 3-BENZYLIDE CAMPHER COMPOUNDS | |
EP1341752A1 (en) | Novel indanylidene compounds | |
US5175340A (en) | New liposoluble unsaturated benzalmalonate derivatives and their use as absorbers for ultraviolet radiation in cosmetics | |
EP0251398B1 (en) | Novel chromophores, sunscreen compositions and methods for preventing sunburn | |
JP3725564B2 (en) | Benzylidenequinuclidinones | |
JPH04134041A (en) | P-xylidene ketone derivative, ultraviolet absorber containing said derivative and cosmetic containing said absorber | |
JPH04134042A (en) | Styryl ketone derivative, ultraviolet absorber containing said derivative and cosmetic containing said absorber | |
JPH04290882A (en) | Gamma-pyrone derivative and ultraviolet ray absorber and cosmetic containing the same | |
US5146002A (en) | Aroyl ketone derivative, uv ray absorber comprising the same, and cosmetic composition containing the same | |
US5508025A (en) | Naphthalenemethylenemalonic diesters, and UV absorbers and cosmetic compositions containing the diesters | |
US5191121A (en) | Aroyl ketone derivative, UV ray absorber comprising the same, and cosmetic composition containing the same | |
JPH03220153A (en) | Benzoyl pinacolone derivative, uv ray absorbent containing the same and cosmetic containing the same | |
JPH07188208A (en) | Skin external preparation | |
US5229107A (en) | Sunscreen agents, sunscreen compositions and methods for preventing sunburn | |
JPH03188041A (en) | Novel benzoylketone derivative, ultraviolet ray absorbing agent containing same derivative and cosmetic containing same absorbing agent | |
JPH04290842A (en) | Benzoylpinacolone derivative, ultraviolet light absorber and cosmetic containing the same derivative | |
JPH04178368A (en) | Heteroaromatic ketone derivative and uv absorber containing the same derivative and cosmetic containing the same absorber | |
JP3511394B2 (en) | Naphthylmethylenemalonic acid diester derivative, ultraviolet absorber and cosmetic containing the same | |
JPS63101371A (en) | Novel dimethoxybenzalhydantoin derivative | |
JP3345492B2 (en) | 2,6-Naphthalenebis (methylenemalonic diester) derivative, ultraviolet absorber and cosmetic containing the same | |
JPH04290887A (en) | 4,4-dimethyl-1-phenylpentane-1,3-dione derivative, ultraviolet ray absorber and cosmetic containing the same | |
JPH04305558A (en) | Benzoylethaneamide derivative, ultraviolet absorbing agent and cosmetic containing the same derivative |